We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLFD icon
4876
Clearfield
CLFD
$411M
$224K ﹤0.01%
16,074
+12,563
+358% +$163K
KOLD icon
4877
ProShares UltraShort Bloomberg Natural Gas
KOLD
$96.3M
$224K ﹤0.01%
333
+227
+214% +$130K
BRF icon
4878
VanEck Brazil Small-Cap ETF
BRF
$21.9M
$223K ﹤0.01%
13,384
+7,568
+130% +$113K
BWB icon
4879
Bridgewater Bancshares
BWB
$571M
$223K ﹤0.01%
21,813
+4,635
+27% +$44.9K
CEW
4880
WisdomTree Emerging Currency Strategy Fund
CEW
$15.8M
$223K ﹤0.01%
13,004
-28,058
-68% -$473K
ODC icon
4881
Oil-Dri
ODC
$1.44B
$223K ﹤0.01%
12,892
+2,780
+27% +$48.1K
ARQ icon
4882
Arq
ARQ
$84.6M
$221K ﹤0.01%
45,537
-84,934
-65% -$489K
CNR
4883
DELISTED
Cornerstone Building Brands, Inc.
CNR
$221K ﹤0.01%
36,685
-29,626
-45% -$151K
VRS
4884
DELISTED
Verso Corporation
VRS
$221K ﹤0.01%
18,506
-25,252
-58% -$331K
FSKR
4885
DELISTED
FS KKR Capital Corp. II
FSKR
$220K ﹤0.01%
+17,090
New +$226K
BV icon
4886
BrightView Holdings
BV
$1.22B
$219K ﹤0.01%
19,566
+11,368
+139% +$138K
FBK icon
4887
FB Financial Corp
FBK
$3.02B
$219K ﹤0.01%
8,887
+3,496
+65% +$77.9K
IIF
4888
Morgan Stanley India Investment Fund
IIF
$217M
$219K ﹤0.01%
13,457
-2,489
-16% -$35.3K
EIDX
4889
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$219K ﹤0.01%
4,610
+1,304
+39% +$60.6K
DTF
4890
DTF Tax-Free Income 2028 Term Fund
DTF
$80.3M
$218K ﹤0.01%
15,314
-11,557
-43% -$160K
EIRL icon
4891
iShares MSCI Ireland ETF
EIRL
$75.6M
$217K ﹤0.01%
5,738
-663
-10% -$23.2K
FRBA icon
4892
First Bank
FRBA
$464M
$217K ﹤0.01%
33,184
+27,068
+443% +$191K
IDT icon
4893
IDT Corp
IDT
$1.64B
$217K ﹤0.01%
33,290
+28,303
+568% +$167K
NWPX icon
4894
NWPX Infrastructure Inc
NWPX
$1.19B
$217K ﹤0.01%
8,662
+2,057
+31% +$49K
CTMX icon
4895
CytomX Therapeutics
CTMX
$675M
$216K ﹤0.01%
25,929
-956
-4% -$8.88K
DDIV icon
4896
First Trust Exchange-Traded Fund VI First Trust Dorsey Wright Momentum & Dividend ETF
DDIV
$72.8M
$216K ﹤0.01%
10,872
-6,114
-36% -$118K
NHTC icon
4897
Natural Health Trends
NHTC
$14.7M
$216K ﹤0.01%
37,794
+998
+3% +$5.16K
KIN
4898
DELISTED
Kindred Biosciences, Inc.
KIN
$216K ﹤0.01%
47,953
-1,685,206
-97% -$7.53M
OCFT
4899
DELISTED
OneConnect Financial Technology
OCFT
$215K ﹤0.01%
1,172
+970
+480% +$130K
CLWT icon
4900
Euro Tech Holdings
CLWT
$11M
$213K ﹤0.01%
174,093
+59,205
+52% +$56.5K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.